Mental Health Clinics in Richmond, KY Accepting Medicare
35 Mental Health Clinics found. Showing 21 - 35
 Peace Of Mind Counseling Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1503 Lexington Rd, Richmond, KY 40475 Phone: 859-353-8568 Fax: 844-379-6646 |
Bhg Lviii, Llc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1024 Ival James Blvd, Suite C, Obot Room 100, Richmond, KY 40475 Phone: 859-575-1323 Fax: 859-575-1325 |
Creating Boundaries, Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 200 E Main St Ste 208, Richmond, KY 40475 Phone: 488-488-1096 |
Madison Primary Care, Llc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 210 Saint George St, Suite 110, Richmond, KY 40475 Phone: 859-626-9766 Fax: 859-626-0741 |
Roaring Voices Counseling Services Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 212 N 2nd St Ste 100, Richmond, KY 40475 Phone: 937-516-1957 |
Selah Wellness Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 448 Breck Ave, Richmond, KY 40475 Phone: 859-221-7975 |
Beyond Behavior Aba And Learning Center Pllc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 292 S 2nd St, Richmond, KY 40475 Phone: 859-353-5505 |
Peace Of Mind Counseling Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1503 Lexington Rd, Richmond, KY 40475 Phone: 859-353-8568 Fax: 844-379-6646 |
Wee Can Autism And Behavioral Consultation, Llc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 830 Eastern Byp Ste A6, Richmond, KY 40475 Phone: 606-416-9220 |
Rediscover Llc Clinic - Mental Health Medicare: Medicare Enrolled Practice Location: 345 Big Hill Ave, Richmond, KY 40475 Phone: 859-353-5311 |
Live Well Health Solutions Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 124 S Keeneland Dr, Richmond, KY 40475 Phone: 859-624-9699 |
897 Mount Rushmore Drive Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 106 E Main St, Richmond, KY 40475 Phone: 859-951-4440 |
Ethan Health Llc Counselor - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 1623 Foxhaven Dr, Richmond, KY 40475 Phone: 859-317-8714 |
Real Recovery Llc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1623 Foxhaven Dr, Richmond, KY 40475 Phone: 859-625-5235 Fax: 859-625-5237 |
Fm Healing Center, Llc Behavioral Analyst Medicare: Medicare Enrolled Practice Location: 1042 Center Dr, Suite 100, Richmond, KY 40475 Phone: 859-575-1518 Fax: 502-808-6077 |
News Archive
Study reveals need for defining optimal amount of iron in infant formula
A 10-year follow-up study examining iron-fortified vs. low-iron infant formula suggests that infants with high hemoglobin levels who received iron fortified infant formula have poorer long-term developmental outcomes.
Underground transit routes expose passengers to greater concentrations of carcinogens, study finds
According to the U.S. Census Bureau, nearly 90 percent of the 4.5 million workers in the Los Angeles area spend an average of 60 minutes each day commuting on a roadway or railway.
Study shows reduction of brain capillaries in mice immunized with amyloid beta
University of British Columbia researchers have successfully normalized the production of blood vessels in the brain of mice with Alzheimer's disease (AD) by immunizing them with amyloid beta, a protein widely associated with the disease.
Bayer presents results from Phase III ROCKET AF trial for atrial fibrillation at American Heart Association
Bayer today announced the results from the pivotal, double-blind Phase III, ROCKET AF trial. In the study, rivaroxaban demonstrated superiority to warfarin in reducing the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).
PERK inhibition can be a promising therapeutic strategy for neurodegenerative diseases
A major challenge in the field of neurodegeneration is the unclear understanding of neuronal dysfunction. Elucidation of these patho-mechanisms could result in the identification of novel therapeutic targets. In this article, Bell et al. present an exhaustive literature review highlighting the endoplasmic reticulum (ER) kinase PERK as a crucial contributor to systemic and neurodegenerative disorders.
› Verified 3 days ago
- 1
- 2(current)